Leaders in Research
You may view the list of scholars arranged
| Jay M. Edelberg, MD, PhD Group Director, Clinical Biomarkers Discovery Medicine & Clinical Pharmacology Bristol-Myers Squibb & Co.
Dr. Edelberg received his M.D. and Ph.D. degrees from Duke University. He completed residency training in internal medicine at Massachusetts General Hospital and cardiology fellowship training at Beth Israel Hospital in Boston. Dr. Edelberg was then a postdoctoral fellow in the Department of Biology at Massachusetts Institute of Technology. | |
| Primary Research (for Beeson Program): Restoration Of Senescent Cardiac Angiogenic Activity
|
Jay M. Edelberg, M.D., Ph.D., is Group Director of Clinical Biomarkers within Bristol-Myers Squibb. Dr. Edelberg’s clincal research focused on the molecular and cellular basis of the depressed senescent cardiac angiogenic activity. Specifically, he is studying the role of systemically-derived endothelial cells in the restoration of blood vessel growth in the aging heart. This work will provide insight into the potential of novel cell-based therapies may be developed for the treatment of cardiovascular disease in older individuals.